Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

TACC3 (Transforming acidic coiled-coil containing protein 3)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

FGFR3-TACC3 fusion	Glioblastoma	FGFR3-TACC3 fusion	Glioblastoma	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3	anlotinib Sensitive: C3 – Early Trials anlotinib Sensitive : C3
FGFR3-TACC3 fusion	Gallbladder Cancer	FGFR3-TACC3 fusion	Gallbladder Cancer	Debio 1347 Sensitive: C3 – Early Trials Debio 1347 Sensitive : C3	Debio 1347 Sensitive: C3 – Early Trials Debio 1347 Sensitive : C3
FGFR3-TACC3 fusion	Urothelial Cancer	FGFR3-TACC3 fusion	Urothelial Cancer	infigratinib Sensitive: C3 – Early Trials infigratinib Sensitive : C3	infigratinib Sensitive: C3 – Early Trials infigratinib Sensitive : C3
FGFR3-TACC3 fusion	Urothelial Cancer	FGFR3-TACC3 fusion	Urothelial Cancer	Debio 1347 Sensitive: C3 – Early Trials Debio 1347 Sensitive : C3	Debio 1347 Sensitive: C3 – Early Trials Debio 1347 Sensitive : C3
FGFR3-TACC3 F17T8	Urothelial Cancer	FGFR3-TACC3 F17T8	Urothelial Cancer	ABSK091 Sensitive: C3 – Early Trials ABSK091 Sensitive : C3	ABSK091 Sensitive: C3 – Early Trials ABSK091 Sensitive : C3
FGFR3-TACC3 F17T8	Cervical Cancer	FGFR3-TACC3 F17T8	Cervical Cancer	ABSK091 Sensitive: C3 – Early Trials ABSK091 Sensitive : C3	ABSK091 Sensitive: C3 – Early Trials ABSK091 Sensitive : C3
FGFR3-TACC3 fusion	Glioblastoma	FGFR3-TACC3 fusion	Glioblastoma	erdafitinib Sensitive: C3 – Early Trials erdafitinib Sensitive : C3	erdafitinib Sensitive: C3 – Early Trials erdafitinib Sensitive : C3
FGFR3-TACC3 fusion	Non Small Cell Lung Cancer	FGFR3-TACC3 fusion	Non Small Cell Lung Cancer	infigratinib Sensitive: C3 – Early Trials infigratinib Sensitive : C3	infigratinib Sensitive: C3 – Early Trials infigratinib Sensitive : C3
FGFR3-TACC3 fusion	Non Small Cell Lung Cancer	FGFR3-TACC3 fusion	Non Small Cell Lung Cancer	ponatinib Sensitive: C3 – Early Trials ponatinib Sensitive : C3	ponatinib Sensitive: C3 – Early Trials ponatinib Sensitive : C3
TACC3 expression	Rectal Cancer	TACC3 expression	Rectal Cancer	5-fluorouracil Resistant: C3 – Early Trials 5-fluorouracil Resistant : C3	5-fluorouracil Resistant: C3 – Early Trials 5-fluorouracil Resistant : C3
TACC3 expression	Rectal Cancer	TACC3 expression	Rectal Cancer	FOLFOX Resistant: C3 – Early Trials FOLFOX Resistant : C3	FOLFOX Resistant: C3 – Early Trials FOLFOX Resistant : C3
TACC3 expression	Rectal Cancer	TACC3 expression	Rectal Cancer	Resistant: C3 – Early Trials Resistant : C3	Resistant: C3 – Early Trials Resistant : C3